Sage Journals: Discover world-class research

Open access

Research article

First published 2023

The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation

Sun Young Jeong, Jung Yong Hong, Joon Oh Park [...]

Therapeutic Advances in Gastroenterology

Retricted access

Review article

First published 2025-2

KRAS inhibitors in drug resistance and potential for combination therapy

Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale

Tumori Journal

Open access

Review article

First published 2025

Potency and Safety of KRAS G12C Inhibitors in Solid Tumors: A Systematic Review

Sara El Zaitouni, Abdelilah Laraqui, Youssra Boustany [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2023

Direct GDP-KRAS G12C inhibitors and mechanisms of resistance: the tip of the iceberg

Joshua C. Rosen, Adrian Sacher, Ming-Sound Tsao

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS -mutated colorectal cancer

Susmita Ghosh, Fan Fan, Reid Powell [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2021-10

Nonclinical Safety Profile of Sotorasib,a KRAS G12C -Specific Covalent Inhibitor for the Treatment of KRAS p.G12C -Mutated Cancer

Katsu Ishida, Jonathan A. Werner, Rhian Davies [...]

International Journal of Toxicology

Open access

Research article

First published 2019

Deregulation of a Network of mRNA and miRNA Genes Reveals That CK2 and MEK Inhibitors May Synergize to Induce Apoptosis KRAS-Active NSCLC

Madeline Krentz Gober, Robert M Flight, Joshua Lambert [...]

Cancer Informatics

Open access

Research article

First published 2019

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2009-11

Review: Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer

Fotios Loupakis, Chiara Cremolini, Gabriella Fontanini [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Immunotherapy in advanced,KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directions

Nadia Ghazali, Marina C. Garassino, Natasha B. Leighl [...]

Therapeutic Advances in Medical Oncology

Search results